美国食品药品监督管理局（FDA）与ICU医疗公司目前仍在积极评估潜在高风险静脉输液管组件的波及范围，旨在精准识别可能受影响的特定型号、生产批次及唯一器械标识。双方正协同审查相关数据，以全面界定问题的性质与规模。
美国食品药品监督管理局（FDA）与ICU医疗公司目前仍在积极评估潜在高风险静脉输液管组件的波及范围，旨在精准识别可能受影响的特定型号、生产批次及唯一器械标识。双方正协同审查相关数据，以全面界定问题的性质与规模。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.